All Releases
 |
Questcor Pharmaceuticals to Present at Bank of America Merrill Lynch 2013 Healthcare Conference
May 8, 2013
|
8.5 KB |
|
| |
ANAHEIM, Calif., May 8, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Bank of America Merrill Lynch 2013 Healthcare Conference in Las Vegas on May 14, 2013 at 4:20 PM PT/7:20 PM ET.
A live webcast and subsequent archived replay of the presentation will be acce...
|
|
Questcor Reports First Quarter Financial Results
Apr 30, 2013
|
40.1 KB |
|
| |
ANAHEIM, Calif., April 30, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today reported financial results for the first quarter ended March 31, 2013. Financial results include BioVectra Inc. since January 18, 2013.
Three Months Ended 03/31/13
Three Months Ended 03/31/12
Percen...
|
|
Questcor to Report First Quarter Results on April 30, 2013
Apr 15, 2013
|
9.2 KB |
|
| |
ANAHEIM, Calif., April 15, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it will release first quarter 2013 financial results on Tuesday, April 30, 2013 after the close of the U.S. financial markets. The Company will host a conference call and slide presentation via webcast on Tuesday, April 30, 2013 at 4:...
|
|
Questcor Reports Fourth Quarter and Full Year 2012 Results
Feb 26, 2013
|
41.1 KB |
|
| |
ANAHEIM, Calif., Feb. 26, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today reported financial results for the fourth quarter and full year ended December 31, 2012.
Three Months Ended 12/31/12
Three Months Ended 12/31/11
Percentage Change
Net Sales
$1...
|
|
Questcor to Report Fourth Quarter and Full Year 2012 Financial Results on February 26, 2013
Feb 6, 2013
|
9.1 KB |
|
| |
ANAHEIM, Calif., Feb. 6, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it will release fourth quarter and full year 2012 financial results on Tuesday, February 26, 2013 after the close of the U.S. financial markets. The Company will host a conference call and slide presentation via webcast on Tuesday, Febr...
|
|
Questcor Pharmaceuticals Appoints Michael Aldridge to the Position of Senior Vice President, Corporate Strategic Development
Jan 28, 2013
|
9.9 KB |
|
| |
ANAHEIM, Calif., Jan. 28, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced the appointment of Michael Aldridge to the new position of Senior Vice President, Corporate Strategic Development. Mr. Aldridge's primary responsibilities will be the identification and development of partnership and acquisition opportuniti...
|
|
Questcor Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Jan 3, 2013
|
8.4 KB |
|
| |
ANAHEIM, Calif., Jan. 3, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management is scheduled to present at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Thursday, January 10, 2013 at 9:00 a.m. PT / 12:00 p.m. ET.
A live webcast with accompanying slide...
|
|
Questcor Pharmaceuticals to Acquire BioVectra Inc.
Jan 2, 2013
|
13.9 KB |
|
| |
ANAHEIM, Calif., Jan. 2, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it has signed a definitive agreement to acquire all issued and outstanding shares of BioVectra Inc., for an upfront payment of C$50 million. BioVectra is a supplier of contract manufacturing services to the global pharmaceutical and bio...
|
|
Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
Dec 4, 2012
|
11.6 KB |
|
| |
ANAHEIM, Calif., Dec. 4, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share to all shareholders of record at the close of business on December 14, 2012. The dividend will be paid in lieu of the Company's regular quarterly cash divid...
|
|
Questcor and Child Neurology Foundation Support the 4th Annual Infantile Spasms Awareness Week
Dec 3, 2012
|
12.0 KB |
|
| |
HAYWARD, Calif., Dec. 3, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it is again partnering with the Child Neurology Foundation (CNF) in support of the 4th annual Infantile Spasms Awareness Week, which will take place December 3 - 12, 2012.
As part of this education effort, CNF has developed a web...
|
|
Questcor Teams With Child Neurology Foundation To Continue Funding Infantile Spasms Scientific Research
Dec 3, 2012
|
10.9 KB |
|
| |
HAYWARD, Calif., Dec. 3, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced that it is again partnering with the Child Neurology Foundation (CNF) to fund a $30,000 grant to support research into infantile spasms. Dr. Alex R. Paciorkowski of the University of Rochester Medical Center was selected by CNF as the recipient of ...
|
|
Questcor Reports Third Quarter Financial Results
Oct 23, 2012
|
45.1 KB |
|
| |
ANAHEIM, Calif., Oct. 23, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today reported financial results for the third quarter and nine months ended September 30, 2012.
Three Months Ended 9/30/12
Three Months Ended 9/30/11
Percentage Change
Net Sales
$140....
|
|
Questcor to Report Third Quarter Results on October 23, 2012
Oct 15, 2012
|
9.1 KB |
|
| |
ANAHEIM, Calif., Oct. 15, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it will release third quarter 2012 financial results on Tuesday, October 23, 2012 after the close of the U.S. financial markets. The Company will host a conference call and slide presentation via webcast on Tuesday, October 23, 2012 at ...
|
|
Questcor Pharmaceuticals Initiates Quarterly Cash Dividend and Expands Stock Repurchase Program
Sep 28, 2012
|
11.5 KB |
|
| |
ANAHEIM, Calif., Sept. 28, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that its Board of Directors has adopted a policy to pay a regular quarterly dividend in such amounts as the Board of Directors may determine from time to time. The Board of Directors has declared an initial quarterly cash dividend of $0.20...
|
|
Questcor to Conduct Conference Call to Discuss Reimbursement Process
Sep 19, 2012
|
9.0 KB |
|
| |
ANAHEIM, Calif., Sept. 19, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it will conduct a conference call to discuss the reimbursement process for H.P. Acthar Gel (repository corticotrophin injection) prescriptions. The call will take place on Thursday, September 20, 2012 at 11 a.m. ET, 8 a.m. PT. The cal...
|
|
Questcor Comments on Insurance Policy Bulletin
Sep 19, 2012
|
9.8 KB |
|
| |
ANAHEIM, Calif., Sept.19, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today commented on information regarding an insurance policy bulletin issued with respect to the Company's primary product H.P. Acthar® Gel (repository corticotropin injection) ("Acthar").
The Company is continuing to review the Clinical Policy ...
|
|
Questcor and The Myositis Association Team Up To Support Research and Educational Initiatives in Polymyositis and Dermatomyositis
Sep 13, 2012
|
10.6 KB |
|
| |
ANAHEIM, Calif., Sept. 13, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that the company will be teaming up with The Myositis Association (TMA) to support research and educational initiatives in dermatomyositis and polymyositis.
"Questcor is very pleased to be able to make this commitment to The Myositis...
|
|
Questcor Pharmaceuticals to Present at Investor Conferences in September
Sep 5, 2012
|
8.6 KB |
|
| |
ANAHEIM, Calif., Sept. 5, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the following investor conferences in September 2012:
Morgan Stanley Global Healthcare Conference in New York City on September 11, 2012 at 3:30 PM ET.
G9: ThinkEquity's 9th Annual Gr...
|
|
Questcor Reports Second Quarter Financial Results
Jul 24, 2012
|
44.2 KB |
|
| |
ANAHEIM, Calif., July 24, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today reported financial results for the second quarter and six months ended June 30, 2012.
Three Months
Ended 6/30/12
Three Months
Ended 6/30/11
Percentage
Change
Net Sales
...
|
|
Questcor to Report Second Quarter Results on July 24, 2012
Jul 10, 2012
|
9.1 KB |
|
| |
ANAHEIM, Calif., July 10, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) today announced that it will release second quarter 2012 financial results on Tuesday, July 24, 2012 after the close of the U.S. financial markets. The Company will host a conference call and slide presentation via webcast on Tuesday, July 24, 2012 at 4:30 p...
|
|
|
